Search - tctmd.com

Displaying 181 - 200 of 606

Sort: Relevancy | Date

Presentation TCT 2017

Topic 1: How Should We Evaluate Technologies in Their Infancy? TAVR, Renal Denervation, BVS, LAA Closure, Mechanical Circulatory Support, and More

Presenter: Robert A. Byrne, Gregg W. Stone, Aaron V. Kaplan

October 30, 2017

Presentation TCT 2017

Aortic Stenosis Population Oddities Who are the Patients Not Being Diagnosed or Treated?

Presenter: Robert O. Bonow, Michael J. Mack, Maurice E. Sarano

October 30, 2017

Presentation TCT 2017

LAA Closure Plus ... TAVR, MitraClip, and More

Presenter: Christopher B. Granger, Horst Sievert, Samir R. Kapadia

October 30, 2017

Presentation TCT 2017

Counterpoint Access to Modern Valve Therapies for Underserved Populations Trumps Arbitrary Guidelines Favoring High-Volume Urban Centers!

Presenter: Uzoma Ibebuogu

October 30, 2017

Presentation TCT 2017

Point A Tiered Centers of Excellence Approach Makes Sense!

Presenter: Patrick T. O'Gara

October 30, 2017

Presentation TCT 2017

Counterpoint In the Modern Era, Crowd Wisdom, Cumulative Experience and New Technology Trumps Case Volume!

Presenter: Martin B. Leon

October 30, 2017

Presentation TCT 2017

Point - Clearly, The More You Do, The Better You Are!

Presenter: John D. Carroll

October 30, 2017

Presentation TCT 2017

Featured Lecture: The Vancouver Multidisciplinary, Multimodality, but Minimalist Clinical Pathway Facilitates Safe Next Day Discharge Home at Low, Medium, and High Volume Transcatheter Aortic Valve Replacement Centres: the 3M TAVR Study

Presenter: Robert O. Bonow, Michael J. Mack, David A. Wood

October 30, 2017

Presentation TCT 2017

Staging Classification of Aortic Stenosis Based Upon the Extent of Cardiac Damage A Novel Concept

Presenter: Robert O. Bonow, Michael J. Mack, Philippe Genereux

October 30, 2017

Presentation TCT 2017

Refining the Classic Definition of Aortic Stenosis: A Dynamic Interpretation Including the Role of Ventricular Stroke Work and Vascular Impedance

Presenter: Robert O. Bonow, Michael J. Mack, Elazer R. Edelman

October 30, 2017

Presentation TCT 2017

Case #8: Transseptal Mitral ViMAC With SAPIEN 3 (With Discussion)

Presenter: Mayra Guerrero, Nicolas M. Van Mieghem

October 30, 2017

Presentation TCT 2017

Case #7: Transapical Mitral ViMAC With Lotus (With Discussion)

Presenter: Mayra Guerrero, Nicolas M. Van Mieghem, Christopher U. Meduri

October 30, 2017

Presentation TCT 2017

Keynote Lecture. European Commission: Evolving Impact of Device Regulation in Europe

Presenter: Gregg W. Stone, Bram D. Zuckerman, Alan G. Fraser

October 30, 2017

Presentation TCT 2017

Keynote Lecture - FDA/CDRH: Evolving Impact of Device Regulation in the US

Presenter: Gregg W. Stone, Bram D. Zuckerman, William H. Maisel

October 30, 2017

Presentation TCT 2017

Case #6: LAMPOON-Facilitated Trans-septal Mitral ViR (With Discussion)

Presenter: Mayra Guerrero, Nicolas M. Van Mieghem, Adam B. Greenbaum

October 30, 2017

Presentation TCT 2017

The Impact of Regulation on Forty Years of PCI and 15 years of TAVR: Industry Perspectives

Presenter: Gregg W. Stone, Bram D. Zuckerman, Richard E. Kuntz

October 30, 2017

Presentation TCT 2017

The Impact of Regulation on Forty Years of PCI and 15 years of TAVR: Physician-Scientist Perspectives

Presenter: Gregg W. Stone, Bram D. Zuckerman

October 30, 2017

Presentation TCT 2017

Case #5: Trans-septal Mitral ViR (With Discussion)

Presenter: Mayra Guerrero, Nicolas M. Van Mieghem, Isaac George

October 30, 2017

Presentation TCT 2017

Case #4: Trans-septal Mitral ViV With SAPIEN 3 (With Discussion)

Presenter: Mayra Guerrero, Nicolas M. Van Mieghem, Mackram F. Eleid

October 30, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day One

Shelley Wood

October 30, 2017

Advertisement

Topic 1: How Should We Evaluate Technologies in Their Infancy? TAVR, Renal Denervation, BVS, LAA Closure, Mechanical Circulatory Support, and More

Aortic Stenosis Population Oddities Who are the Patients Not Being Diagnosed or Treated?

LAA Closure Plus ... TAVR, MitraClip, and More

Counterpoint Access to Modern Valve Therapies for Underserved Populations Trumps Arbitrary Guidelines Favoring High-Volume Urban Centers!

Point A Tiered Centers of Excellence Approach Makes Sense!

Counterpoint In the Modern Era, Crowd Wisdom, Cumulative Experience and New Technology Trumps Case Volume!

Point - Clearly, The More You Do, The Better You Are!

Featured Lecture: The Vancouver Multidisciplinary, Multimodality, but Minimalist Clinical Pathway Facilitates Safe Next Day Discharge Home at Low, Medium, and High Volume Transcatheter Aortic Valve Replacement Centres: the 3M TAVR Study

Staging Classification of Aortic Stenosis Based Upon the Extent of Cardiac Damage A Novel Concept

Refining the Classic Definition of Aortic Stenosis: A Dynamic Interpretation Including the Role of Ventricular Stroke Work and Vascular Impedance

Case #8: Transseptal Mitral ViMAC With SAPIEN 3 (With Discussion)

Case #7: Transapical Mitral ViMAC With Lotus (With Discussion)

Keynote Lecture. European Commission: Evolving Impact of Device Regulation in Europe

Keynote Lecture - FDA/CDRH: Evolving Impact of Device Regulation in the US

Case #6: LAMPOON-Facilitated Trans-septal Mitral ViR (With Discussion)

The Impact of Regulation on Forty Years of PCI and 15 years of TAVR: Industry Perspectives

The Impact of Regulation on Forty Years of PCI and 15 years of TAVR: Physician-Scientist Perspectives

Case #5: Trans-septal Mitral ViR (With Discussion)

Case #4: Trans-septal Mitral ViV With SAPIEN 3 (With Discussion)

Live From Denver: TCT 2017, Day One

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content